Cargando…
Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
Expression of miR-154 is upregulated in the diseased heart and was previously shown to be upregulated in the lungs of patients with pulmonary fibrosis. However, the role of miR-154 in a model of sustained pressure overload-induced cardiac hypertrophy and fibrosis had not been assessed. To examine th...
Autores principales: | Bernardo, Bianca C., Nguyen, Sally S., Gao, Xiao-Ming, Tham, Yow Keat, Ooi, Jenny Y. Y., Patterson, Natalie L., Kiriazis, Helen, Su, Yidan, Thomas, Colleen J., Lin, Ruby C. Y., Du, Xiao-Jun, McMullen, Julie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772383/ https://www.ncbi.nlm.nih.gov/pubmed/26928825 http://dx.doi.org/10.1038/srep22442 |
Ejemplares similares
-
Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
por: Bernardo, Bianca C., et al.
Publicado: (2014) -
Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation
por: Bernardo, Bianca C., et al.
Publicado: (2015) -
The Interplay of Protein Coding and Non-Coding RNAs (circRNAs, lncRNAs) During Cardiac Differentiation
por: McMullen, Julie R., et al.
Publicado: (2017) -
In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
por: Bernardo, Bianca C., et al.
Publicado: (2022) -
Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
por: Horlock, Duncan, et al.
Publicado: (2021)